Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2013
Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features
Loretta Gammaitoni, Lidia Giraudo, Valeria Leuci, et al.
Cancer Research
|
December 21, 2013
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas
Dario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST
Erika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2017
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
Fabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2016
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells
Loretta Gammaitoni, Lidia Giraudo, Marco Macagno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2020
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Valeria Leuci, Chiara Donini, Giovanni Grignani, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 23, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2013
Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features
Loretta Gammaitoni, Lidia Giraudo, Valeria Leuci, et al.
Cancer Research
|
December 21, 2013
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas
Dario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST
Erika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2017
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
Fabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2016
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells
Loretta Gammaitoni, Lidia Giraudo, Marco Macagno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2020
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Valeria Leuci, Chiara Donini, Giovanni Grignani, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 23, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Page
of 2